Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Dogwood Therapeutics, Inc (DWTX) had Return on Tangible Equity of 58.22% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.78M |
|
-- |
|
-- |
|
$3.81M |
|
$-3.81M |
|
$0.06M |
|
$-3.75M |
|
$-3.75M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.78M |
|
$-3.81M |
|
$-3.81M |
|
4.98M |
|
4.98M |
|
$11.51 |
|
$11.51 |
|
| Balance Sheet Financials | |
$8.43M |
|
$0.01M |
|
$81.74M |
|
$90.17M |
|
$3.06M |
|
-- |
|
$12.22M |
|
$15.27M |
|
$74.90M |
|
$-6.49M |
|
$74.90M |
|
29.74M |
|
| Cash Flow Statement Financials | |
$-15.62M |
|
-- |
|
$7.28M |
|
$14.85M |
|
$6.52M |
|
$-8.32M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.04% |
|
|
Return on Tangible Equity |
58.22% |
-4.19% |
|
-5.04% |
|
$2.52 |
|
$-3.14 |
|
$-3.14 |
|